Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD

ClinicalTrials.gov ID: NCT02467634

Public ClinicalTrials.gov record NCT02467634. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 13, 2026, 1:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A fellow eye controlled study of HUCNS-SC sub-retinal transplantation in subjects with bilateral GA AMD. All subjects will be assigned to HUCNS-SC transplantation.

Study identification

NCT ID
NCT02467634
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
StemCells, Inc.
Industry
Enrollment
3 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2015
Primary completion
Apr 30, 2016
Completion
Apr 30, 2016
Last update posted
Jun 1, 2016

2015 – 2016

United States locations

U.S. sites
12
U.S. states
7
U.S. cities
12
Facility City State ZIP Site status
Retina Associates Southwest, PC Tucson Arizona 85724
Retina Vitreous Associates Medical Group Beverly Hills California 90211
Retinal Diagnostic Center Campbell California 95008
Northern California Retina Vitreous Associates Mountain View California 94040
Retina Research Institute of Texas Palo Alto California 94303
Rush University Med Ctr. Chicago Illinois 60612
William Beaumont Health System Royal Oak Michigan 48073
New York Eye and Ear Infirmary New York New York 10003
Retina Research Institute of Texas Abilene Texas 79606
Retina Research Center Austin Texas 78705
Retina Foundation of the Southwest Dallas Texas 75231
University Of Utah / John A. Moran Eye Center Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02467634, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2016 · Synced Sep 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02467634 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →